S. Subramanian

发表

Infliximab induction regimens in steroid‐refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysis

N. Kennedy, J. Brooks, G. Moran, 2019, Alimentary pharmacology & therapeutics.

PTU-049 Concurrent Immunomodulator Therapy does not Influence Infliximab or Adalimumab Trough Levels During Maintenance Therapy

A. Bond, T. Skouras, S. Subramanian, 2016 .

A propensity score‐matched, real‐world comparison of ustekinumab vs vedolizumab as a second‐line treatment for Crohn’s disease. The Cross Pennine study II

A. de Silvestri, C. Stansfield, C. Selinger, 2021, Alimentary pharmacology & therapeutics.

Autologous stem cell transplantation in refractory Crohn’s disease – low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study

R. Emsley, M. Parkes, J. Satsangi, 2019, BMC Gastroenterology.